- Home
- QLGN vs ACON Comparison
QLGN vs ACON Comparison
Compare QLGN & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- ACON
- Stock Information
- Founded
- QLGN 1996
- ACON 2008
- Country
- QLGN United States
- ACON United States
- Employees
- QLGN N/A
- ACON N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- QLGN Health Care
- ACON Technology
- Exchange
- QLGN Nasdaq
- ACON Nasdaq
- Market Cap
- QLGN 4.8M
- ACON 4.4M
- IPO Year
- QLGN N/A
- ACON 2022
- Fundamental
- Price
- QLGN $5.02
- ACON $8.05
- Analyst Decision
- QLGN
- ACON Buy
- Analyst Count
- QLGN 0
- ACON 2
- Target Price
- QLGN N/A
- ACON $22.00
- AVG Volume (30 Days)
- QLGN 4.8M
- ACON 18.5K
- Earning Date
- QLGN 11-13-2025
- ACON 11-13-2025
- Dividend Yield
- QLGN N/A
- ACON N/A
- EPS Growth
- QLGN N/A
- ACON N/A
- EPS
- QLGN N/A
- ACON N/A
- Revenue
- QLGN N/A
- ACON $62,948.00
- Revenue This Year
- QLGN N/A
- ACON $145.39
- Revenue Next Year
- QLGN N/A
- ACON $145.45
- P/E Ratio
- QLGN N/A
- ACON N/A
- Revenue Growth
- QLGN N/A
- ACON 16.68
- 52 Week Low
- QLGN $1.61
- ACON $6.20
- 52 Week High
- QLGN $10.45
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- QLGN 61.57
- ACON 55.98
- Support Level
- QLGN $4.91
- ACON $7.25
- Resistance Level
- QLGN $6.16
- ACON $9.57
- Average True Range (ATR)
- QLGN 1.00
- ACON 0.57
- MACD
- QLGN 0.06
- ACON -0.04
- Stochastic Oscillator
- QLGN 43.01
- ACON 34.45
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.